Back icon Back
NewLimit

NewLimit

Company

NewLimit raises $130 million Series B led by Kleiner Perkins alongside NFDG, Khosla Ventures, Human Capital and others
NewLimit is developing medicines to extend human healthspan through epigenetic reprogramming
We founded NewLimit to develop medicines that add healthy years to each human life. Initially, we thought it would take many years to show progress

https://blog.newlimit.com/p/newlimit-raises-130-million-series

Date

May 6, 2025

Category

biotech

Lead investor

Country Icon Kleiner Perkins

Stage

Series B

Size

$130M

Explore similar Investments to NewLimit

Company
Size
Date
Lead Investor
Press
Nace AI

Nace AI

Company
$5M
Mar 24, 2025
Investor General Catalyst
Source
Augment Code

Augment Code

Company
$227M
Apr 26, 2024
Investor Index Ventures
Source
Lovable

Lovable

Company
$7.5M
Oct 7, 2024
Investor Hummingbird VC
Source
Cortex

Cortex

Company
$60M
Sep 4, 2024
Investor IVP
Source
Rive

Rive

Company
$10M
Jan 19, 2024
Investor Two Sigma Ventures
Source
Podcastle

Podcastle

Company
$13.5M
Feb 1, 2024
Investor Mosaic Ventures
Source
Blackbird

Blackbird

Company
$50M
Apr 8, 2025
Investor Spark Capital
Source
Anysphere

Anysphere

Company
$900M
Jun 6, 2025
Investor Thrive Capital
Source
Keep

Keep

Company
$23M
May 20, 2025
Investor Tribe Capital
Source
Slash

Slash

Company
$41M
May 23, 2025
Investor Goodwater Capital
Source
Harvey

Harvey

Company
$300M
Jun 23, 2025
Investor Kleiner Perkins
Source
Collate

Collate

Company
$30M
Jan 13, 2025
Investor Redpoint Ventures
Source

Startups, venture funds
& everything in between.

Explore verified companies, top VCs, and practical guides built to help you raise, invest, and grow faster.
Made by Omnius. For builders, by builders.
Venture Funds Startups Investments Events Programs Case Studies Interviews & Lectures Reports & Publications